The debut of troglitazone, a potent glucose-lowering agent, marked a significant chapter in the management of type 2 diabetes. However, its discontinuation from the market due to severe hepatotoxicity spurred broad https://laytnwpzu090357.aboutyoublog.com/51645492/troglityzone-and-related-thiazolidinediones-a-relative-overview